Vira Therapeutics
Develops highly potent anti-cancer therapeutics based on oncolytic viruses - making cancer immunotherapies more powerful.
Launch date
Employees
Market cap
-
Enterprise valuation
€210m (Public information from Sep 2018)
Company register number FN 397151 x (Innsbruck)
Innsbruck Tyrol (HQ)
Financials
Estimates*
EUR | 2021 | 2022 | 2023 |
---|---|---|---|
Profit | <1m | 3.6m | 2.5m |
Date | Investors | Amount | Round |
---|---|---|---|
* | N/A | Spinout | |
€3.6m | Series A | ||
* | €210m Valuation: €210m | Acquisition | |
Total Funding | €3.6m |
Related Content
Recent News about Vira Therapeutics
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.